Nature Reviews Clinical Oncology

Vol. 22, Issue 11 Issue 11 2025
9
Articles

Articles in this Issue

ALASCCA: an aspirin a day keeps colorectal cancer away

David Killock Nov 01, 2025 pp. 801-801 10.1038/s41571-025-01082-2

MARIPOSA demonstrates overall survival benefit from amivantamab–lazertinib

Diana Romero Nov 01, 2025 pp. 801-801 10.1038/s41571-025-01081-3

Maintenance tarlatamab extends overall survival

Peter Sidaway Nov 01, 2025 pp. 801-801 10.1038/s41571-025-01078-y

The molecular blueprint of targeted radionuclide therapy

Irina Primac, Kevin Tabury, Alpaslan Tasdogan et al. Nov 01, 2025 pp. 869-894 10.1038/s41571-025-01069-z

Radiomics Quality Score 2.0: towards radiomics readiness levels and clinical translation for personalized medicine

Philippe Lambin, Henry C. Woodruff, Shruti Atul Mali et al. Nov 01, 2025 pp. 831-846 10.1038/s41571-025-01067-1

Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia

Antonino Glaviano, Ellen Weisberg, Hiu Y. Lam et al. Nov 01, 2025 pp. 847-868 10.1038/s41571-025-01068-0

Treatment of NSCLC after chemoimmunotherapy — are we making headway?

Martin Reck, Nikolaj Frost, Solange Peters et al. Nov 01, 2025 pp. 806-830 10.1038/s41571-025-01061-7

SERENA-6: dynamic ctDNA assessment and the future of precision cancer medicine

Arielle J. Medford, Seth A. Wander Nov 01, 2025 pp. 804-805 10.1038/s41571-025-01066-2

Surprising role of CMV in shaping outcomes of immunotherapy for melanoma — chronic infection yields favourable survival

Anthony R. Cillo, John M. Kirkwood Nov 01, 2025 pp. 802-803 10.1038/s41571-025-01065-3

All Issues

Journal Info

Publisher Springer Science and Business Media LLC
ISSN 1759-4774
E-ISSN 1759-4782
Subject Medicine
Language English
View Full Journal Page